Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 95 | 2024 | 3224 | 7.350 |
Why?
|
Genome-Wide Association Study | 74 | 2024 | 12626 | 2.760 |
Why?
|
Idiopathic Pulmonary Fibrosis | 10 | 2024 | 502 | 2.210 |
Why?
|
Pulmonary Emphysema | 14 | 2024 | 688 | 1.980 |
Why?
|
Genetic Predisposition to Disease | 58 | 2024 | 17790 | 1.810 |
Why?
|
Polymorphism, Single Nucleotide | 59 | 2024 | 15789 | 1.680 |
Why?
|
Smoking | 37 | 2024 | 9073 | 1.630 |
Why?
|
Lung | 44 | 2024 | 9994 | 1.430 |
Why?
|
Genetic Loci | 17 | 2023 | 2618 | 1.300 |
Why?
|
Forced Expiratory Volume | 23 | 2024 | 1809 | 1.130 |
Why?
|
Lung Diseases, Interstitial | 6 | 2023 | 911 | 0.960 |
Why?
|
Emphysema | 5 | 2023 | 240 | 0.900 |
Why?
|
Bronchiectasis | 4 | 2023 | 139 | 0.770 |
Why?
|
Asthma | 12 | 2023 | 6172 | 0.660 |
Why?
|
Spirometry | 13 | 2024 | 924 | 0.660 |
Why?
|
Pulmonary Diffusing Capacity | 2 | 2018 | 94 | 0.650 |
Why?
|
Respiratory Tract Diseases | 1 | 2024 | 748 | 0.640 |
Why?
|
Genetic Pleiotropy | 1 | 2019 | 181 | 0.590 |
Why?
|
Adrenal Insufficiency | 1 | 2018 | 192 | 0.520 |
Why?
|
Phenotype | 27 | 2024 | 16546 | 0.520 |
Why?
|
Genetic Variation | 8 | 2024 | 6551 | 0.480 |
Why?
|
Respiratory Function Tests | 9 | 2024 | 1683 | 0.470 |
Why?
|
Quantitative Trait Loci | 13 | 2024 | 2101 | 0.460 |
Why?
|
Severity of Illness Index | 10 | 2023 | 15840 | 0.450 |
Why?
|
Cystic Fibrosis | 1 | 2023 | 1274 | 0.450 |
Why?
|
Mucus | 3 | 2024 | 342 | 0.440 |
Why?
|
Matrix Metalloproteinase 12 | 2 | 2010 | 44 | 0.440 |
Why?
|
Mucin-5B | 4 | 2023 | 147 | 0.440 |
Why?
|
Mortality | 1 | 2024 | 2916 | 0.430 |
Why?
|
Linkage Disequilibrium | 6 | 2023 | 1996 | 0.400 |
Why?
|
Humans | 144 | 2024 | 760621 | 0.390 |
Why?
|
Vital Capacity | 7 | 2024 | 965 | 0.390 |
Why?
|
Receptors, Nicotinic | 5 | 2019 | 494 | 0.380 |
Why?
|
Cluster Analysis | 6 | 2023 | 2698 | 0.380 |
Why?
|
Genomics | 8 | 2024 | 5794 | 0.370 |
Why?
|
Body Mass Index | 6 | 2024 | 12914 | 0.370 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 347 | 0.360 |
Why?
|
Proteomics | 4 | 2024 | 3817 | 0.360 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2010 | 142 | 0.340 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4713 | 0.320 |
Why?
|
Adrenal Cortex Hormones | 1 | 2018 | 1869 | 0.320 |
Why?
|
GTPase-Activating Proteins | 4 | 2019 | 475 | 0.310 |
Why?
|
Genome, Human | 5 | 2019 | 4417 | 0.300 |
Why?
|
Case-Control Studies | 20 | 2024 | 22053 | 0.300 |
Why?
|
Middle Aged | 60 | 2024 | 220352 | 0.290 |
Why?
|
Aged | 51 | 2024 | 169152 | 0.290 |
Why?
|
Genome | 3 | 2024 | 1739 | 0.290 |
Why?
|
Elastin | 1 | 2008 | 301 | 0.280 |
Why?
|
Tomography, X-Ray Computed | 17 | 2023 | 20509 | 0.270 |
Why?
|
Male | 72 | 2024 | 359744 | 0.270 |
Why?
|
Models, Genetic | 7 | 2024 | 3442 | 0.260 |
Why?
|
Databases, Genetic | 4 | 2019 | 1738 | 0.260 |
Why?
|
Female | 72 | 2024 | 391270 | 0.250 |
Why?
|
Proteome | 3 | 2024 | 1855 | 0.250 |
Why?
|
Chromosomes, Human, Pair 4 | 4 | 2024 | 377 | 0.250 |
Why?
|
Arthritis, Rheumatoid | 3 | 2024 | 3763 | 0.230 |
Why?
|
Lung Diseases | 3 | 2024 | 1915 | 0.230 |
Why?
|
Hexosyltransferases | 1 | 2023 | 58 | 0.230 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15757 | 0.220 |
Why?
|
Polymorphism, Genetic | 4 | 2017 | 4291 | 0.220 |
Why?
|
Iron Regulatory Protein 2 | 3 | 2013 | 42 | 0.220 |
Why?
|
Polyadenylation | 1 | 2024 | 117 | 0.220 |
Why?
|
Genetic Association Studies | 5 | 2023 | 2717 | 0.220 |
Why?
|
Pneumothorax | 1 | 2006 | 379 | 0.210 |
Why?
|
Gene Expression | 8 | 2023 | 7588 | 0.210 |
Why?
|
Multifactorial Inheritance | 4 | 2024 | 1365 | 0.200 |
Why?
|
Cause of Death | 3 | 2024 | 3725 | 0.200 |
Why?
|
Cohort Studies | 15 | 2023 | 41335 | 0.200 |
Why?
|
Somatomedins | 1 | 2022 | 178 | 0.200 |
Why?
|
3' Untranslated Regions | 1 | 2024 | 514 | 0.200 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2022 | 113 | 0.200 |
Why?
|
Activin Receptors, Type I | 2 | 2019 | 136 | 0.190 |
Why?
|
DNA | 3 | 2011 | 7233 | 0.190 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2023 | 1846 | 0.190 |
Why?
|
Risk Factors | 20 | 2024 | 74359 | 0.190 |
Why?
|
Genotype | 13 | 2023 | 12960 | 0.190 |
Why?
|
Gene Regulatory Networks | 4 | 2024 | 1741 | 0.180 |
Why?
|
Mosaicism | 1 | 2024 | 466 | 0.180 |
Why?
|
Blood Cells | 1 | 2022 | 305 | 0.180 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2023 | 1245 | 0.180 |
Why?
|
Genetic Markers | 6 | 2024 | 2608 | 0.170 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2023 | 446 | 0.170 |
Why?
|
Mucins | 1 | 2023 | 568 | 0.170 |
Why?
|
Hypersensitivity, Immediate | 1 | 2023 | 345 | 0.170 |
Why?
|
Family | 3 | 2017 | 3189 | 0.170 |
Why?
|
3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2019 | 56 | 0.170 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 72 | 0.160 |
Why?
|
Airway Obstruction | 1 | 2024 | 662 | 0.160 |
Why?
|
Tumor Suppressor Proteins | 1 | 2008 | 2802 | 0.160 |
Why?
|
Mutation | 8 | 2024 | 29932 | 0.160 |
Why?
|
Membrane Glycoproteins | 4 | 2013 | 3707 | 0.150 |
Why?
|
Administration, Inhalation | 2 | 2018 | 1156 | 0.150 |
Why?
|
Chromosome Aberrations | 1 | 2024 | 1764 | 0.150 |
Why?
|
Fatty Liver | 1 | 2023 | 778 | 0.140 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2019 | 608 | 0.140 |
Why?
|
Internationality | 1 | 2022 | 1004 | 0.140 |
Why?
|
Hematopoiesis | 2 | 2023 | 2050 | 0.140 |
Why?
|
Hematopoietic Stem Cells | 3 | 2024 | 3387 | 0.140 |
Why?
|
Pulmonary Fibrosis | 2 | 2019 | 506 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4490 | 0.130 |
Why?
|
rac GTP-Binding Proteins | 1 | 2017 | 162 | 0.130 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12531 | 0.130 |
Why?
|
Sputum | 2 | 2023 | 503 | 0.130 |
Why?
|
Carrier Proteins | 4 | 2013 | 4938 | 0.130 |
Why?
|
Respiratory Insufficiency | 1 | 2024 | 1231 | 0.130 |
Why?
|
Adult | 25 | 2024 | 219994 | 0.120 |
Why?
|
Pedigree | 2 | 2016 | 4578 | 0.120 |
Why?
|
Penetrance | 1 | 2017 | 388 | 0.120 |
Why?
|
DNA Methylation | 3 | 2024 | 4373 | 0.120 |
Why?
|
Respiration, Artificial | 1 | 2006 | 2622 | 0.120 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 23 | 0.120 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1841 | 0.120 |
Why?
|
Liver Diseases | 1 | 2023 | 1302 | 0.120 |
Why?
|
Nerve Tissue Proteins | 3 | 2012 | 4407 | 0.120 |
Why?
|
Immunoglobulin E | 3 | 2023 | 1484 | 0.120 |
Why?
|
Biopsy | 1 | 2006 | 6771 | 0.120 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1374 | 0.110 |
Why?
|
Pectoralis Muscles | 1 | 2014 | 85 | 0.110 |
Why?
|
Promoter Regions, Genetic | 4 | 2023 | 5785 | 0.110 |
Why?
|
Reference Standards | 1 | 2017 | 1004 | 0.110 |
Why?
|
Computer Simulation | 5 | 2022 | 6218 | 0.110 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2012 | 48 | 0.110 |
Why?
|
Hypertension, Pulmonary | 1 | 2024 | 1570 | 0.110 |
Why?
|
Receptors, Serotonin, 5-HT4 | 1 | 2012 | 15 | 0.110 |
Why?
|
Age of Onset | 2 | 2017 | 3301 | 0.100 |
Why?
|
Uteroglobin | 1 | 2012 | 56 | 0.100 |
Why?
|
Traction | 2 | 2023 | 106 | 0.100 |
Why?
|
Alleles | 6 | 2024 | 6898 | 0.100 |
Why?
|
Cadherins | 1 | 2017 | 898 | 0.100 |
Why?
|
Longitudinal Studies | 8 | 2024 | 14495 | 0.100 |
Why?
|
Gene Expression Regulation | 6 | 2024 | 11903 | 0.100 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2011 | 74 | 0.100 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2011 | 59 | 0.100 |
Why?
|
Logistic Models | 4 | 2019 | 13314 | 0.090 |
Why?
|
Oxygen | 2 | 2023 | 4193 | 0.090 |
Why?
|
Receptors, Interleukin-17 | 1 | 2011 | 80 | 0.090 |
Why?
|
Desmoplakins | 2 | 2022 | 62 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3758 | 0.090 |
Why?
|
Child | 10 | 2024 | 79806 | 0.090 |
Why?
|
Computational Biology | 3 | 2024 | 3505 | 0.090 |
Why?
|
Aged, 80 and over | 11 | 2019 | 58995 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4107 | 0.090 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 253 | 0.090 |
Why?
|
Disease Progression | 5 | 2019 | 13502 | 0.090 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2011 | 385 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2022 | 4013 | 0.090 |
Why?
|
Multigene Family | 1 | 2013 | 1077 | 0.080 |
Why?
|
Sex Factors | 3 | 2024 | 10547 | 0.080 |
Why?
|
Untranslated Regions | 1 | 2008 | 29 | 0.080 |
Why?
|
Sample Size | 2 | 2022 | 840 | 0.080 |
Why?
|
Transition Temperature | 1 | 2008 | 34 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 951 | 0.080 |
Why?
|
Quantitative Trait, Heritable | 2 | 2024 | 540 | 0.080 |
Why?
|
Enhancer Elements, Genetic | 2 | 2014 | 1356 | 0.080 |
Why?
|
Bronchi | 3 | 2023 | 848 | 0.080 |
Why?
|
Iceland | 2 | 2019 | 184 | 0.080 |
Why?
|
Respiratory Physiological Phenomena | 2 | 2023 | 188 | 0.080 |
Why?
|
Lung Diseases, Obstructive | 1 | 2008 | 309 | 0.070 |
Why?
|
Blood Vessels | 1 | 2013 | 1112 | 0.070 |
Why?
|
Epidemiologic Studies | 1 | 2011 | 670 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2023 | 3517 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2023 | 3663 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2023 | 39261 | 0.070 |
Why?
|
Nutrition Surveys | 2 | 2024 | 1725 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1796 | 0.070 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2008 | 330 | 0.070 |
Why?
|
Surgical Stapling | 1 | 2006 | 98 | 0.060 |
Why?
|
Thoracoscopy | 1 | 2006 | 176 | 0.060 |
Why?
|
Molecular Epidemiology | 2 | 2022 | 469 | 0.060 |
Why?
|
Pneumonia | 1 | 2017 | 2131 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1722 | 0.060 |
Why?
|
Veterans Disability Claims | 1 | 2024 | 24 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1343 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8044 | 0.060 |
Why?
|
Tidal Volume | 1 | 2006 | 487 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9280 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2024 | 151 | 0.060 |
Why?
|
Postoperative Complications | 1 | 2006 | 15697 | 0.060 |
Why?
|
Gene Expression Profiling | 3 | 2023 | 9411 | 0.060 |
Why?
|
Europe | 2 | 2022 | 3441 | 0.050 |
Why?
|
Prevalence | 3 | 2023 | 15687 | 0.050 |
Why?
|
Pressure | 1 | 2006 | 1156 | 0.050 |
Why?
|
Exons | 1 | 2008 | 2388 | 0.050 |
Why?
|
Rodentia | 1 | 2024 | 260 | 0.050 |
Why?
|
Physics | 1 | 2022 | 90 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8056 | 0.050 |
Why?
|
Heterozygote | 1 | 2008 | 2798 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2024 | 659 | 0.050 |
Why?
|
Young Adult | 5 | 2024 | 58741 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4353 | 0.050 |
Why?
|
Bilirubin | 1 | 2023 | 438 | 0.050 |
Why?
|
Chromosome Mapping | 3 | 2015 | 4625 | 0.050 |
Why?
|
Privacy | 1 | 2023 | 233 | 0.050 |
Why?
|
Myosins | 1 | 2022 | 405 | 0.050 |
Why?
|
Immunocompromised Host | 1 | 2006 | 857 | 0.050 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 542 | 0.050 |
Why?
|
Methyltransferases | 1 | 2024 | 374 | 0.050 |
Why?
|
Financing, Government | 1 | 2024 | 472 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25942 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3775 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12293 | 0.040 |
Why?
|
X Chromosome | 1 | 2023 | 815 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6068 | 0.040 |
Why?
|
Lysine | 1 | 2024 | 1001 | 0.040 |
Why?
|
Prospective Studies | 5 | 2024 | 54303 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13262 | 0.040 |
Why?
|
Incidence | 3 | 2023 | 21392 | 0.040 |
Why?
|
Telomerase | 1 | 2024 | 746 | 0.040 |
Why?
|
Radiography | 2 | 2023 | 6965 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1135 | 0.040 |
Why?
|
United States | 6 | 2024 | 72461 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 31 | 0.040 |
Why?
|
Adolescent | 4 | 2024 | 87810 | 0.040 |
Why?
|
Eosinophils | 1 | 2023 | 944 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 979 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2023 | 998 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1139 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 736 | 0.040 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2023 | 1313 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12159 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1407 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 869 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2024 | 1826 | 0.030 |
Why?
|
Prognosis | 4 | 2024 | 29658 | 0.030 |
Why?
|
Algorithms | 3 | 2024 | 13981 | 0.030 |
Why?
|
Nedocromil | 1 | 2016 | 46 | 0.030 |
Why?
|
Gene Frequency | 1 | 2023 | 3615 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5889 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2024 | 1486 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 21025 | 0.030 |
Why?
|
Dyspnea | 1 | 2024 | 1352 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 6029 | 0.030 |
Why?
|
Animals | 6 | 2024 | 167963 | 0.030 |
Why?
|
Cachexia | 1 | 2017 | 198 | 0.030 |
Why?
|
Haplotypes | 2 | 2011 | 2764 | 0.030 |
Why?
|
Budesonide | 1 | 2016 | 158 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2326 | 0.030 |
Why?
|
Mice | 4 | 2024 | 81208 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2024 | 1305 | 0.030 |
Why?
|
Age Factors | 3 | 2019 | 18416 | 0.030 |
Why?
|
Disabled Persons | 1 | 2024 | 1223 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 2014 | 149 | 0.030 |
Why?
|
Inflammation | 2 | 2024 | 10756 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1091 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2005 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2023 | 2566 | 0.030 |
Why?
|
Linear Models | 1 | 2024 | 5877 | 0.030 |
Why?
|
Histones | 1 | 2024 | 2583 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2014 | 362 | 0.030 |
Why?
|
Body Composition | 2 | 2014 | 2419 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 2016 | 506 | 0.030 |
Why?
|
Epigenomics | 1 | 2018 | 936 | 0.030 |
Why?
|
Sp3 Transcription Factor | 1 | 2011 | 28 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1484 | 0.030 |
Why?
|
Demography | 1 | 2017 | 1650 | 0.020 |
Why?
|
Poland | 1 | 2012 | 196 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2014 | 80372 | 0.020 |
Why?
|
Chromosomes, Human | 1 | 2013 | 442 | 0.020 |
Why?
|
Costa Rica | 1 | 2011 | 177 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1726 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10551 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2011 | 295 | 0.020 |
Why?
|
Bronchial Provocation Tests | 1 | 2011 | 216 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1810 | 0.020 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2010 | 75 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 524 | 0.020 |
Why?
|
CpG Islands | 1 | 2015 | 1221 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3568 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2012 | 698 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2011 | 748 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2013 | 441 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2014 | 830 | 0.020 |
Why?
|
Norway | 1 | 2010 | 496 | 0.020 |
Why?
|
Fibrinogen | 1 | 2012 | 886 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2014 | 2381 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2557 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 858 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5791 | 0.020 |
Why?
|
Online Systems | 1 | 2009 | 181 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1894 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 829 | 0.020 |
Why?
|
Risk Assessment | 1 | 2010 | 24123 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1617 | 0.020 |
Why?
|
Angiography | 1 | 2013 | 1605 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
Apoptosis | 1 | 2023 | 9501 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2009 | 565 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23711 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13308 | 0.020 |
Why?
|
tau Proteins | 1 | 2018 | 2085 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3711 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2009 | 594 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3616 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6544 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12808 | 0.020 |
Why?
|
Genetics, Population | 1 | 2009 | 930 | 0.010 |
Why?
|
International Cooperation | 1 | 2011 | 1433 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5039 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4122 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4573 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3442 | 0.010 |
Why?
|
Child, Preschool | 2 | 2016 | 42063 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2192 | 0.010 |
Why?
|
Software | 1 | 2017 | 4419 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3215 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16939 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12766 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4090 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4357 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2012 | 3839 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2629 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4611 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2011 | 2064 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20080 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15620 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15289 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10446 | 0.010 |
Why?
|
Models, Statistical | 1 | 2011 | 5075 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18957 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6659 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2017 | 8547 | 0.010 |
Why?
|
Biomedical Research | 1 | 2011 | 3426 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23376 | 0.010 |
Why?
|
Neoplasms | 1 | 2016 | 22072 | 0.000 |
Why?
|